Article

Identification and Ranking of Recurrent Neo-Epitopes in Cancer

2018-08-10

Abstract excerpt

Immune escape is one of the hallmarks of cancer and several new treatment approaches attempt to modulate and restore the immune system’s capability to target cancer cells. At the heart of the immune recognition process lies antigen presentation from somatic mutations. These neo-epitopes are emerging as attractive targets for cancer immunotherapy and new strategies for rapid identification of relevant candidates ha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3c108473-3c91-5d4a-8aeb-7712ca652782
DOI: 10.1101/389437

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification and Ranking of Recurrent Neo-Epitopes in CancerDOI 10.1101/389437Read

Identification and ranking of recurrent neo-epitopes in cancer.Semantic proximity Read

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy TargetsSemantic proximity Read

The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.Semantic proximity Read

Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.Semantic proximity Read

Predicting T cell recognition of MHC class I restricted neoepitopesSemantic proximity Read

Discovery of prevalent, clinically actionable tumor neoepitopes via integrated biochemical and cell-based platformsSemantic proximity Read

Recurrent Neoantigens in Colorectal Cancer as Potential Immunotherapy Targets.Semantic proximity Read

Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)Semantic proximity Read

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapySemantic proximity Read

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer ImmunotherapySemantic proximity Read

The immunogenic potential of recurrent cancer drug resistance mutations: an <i>in silico</i> studySemantic proximity Read

Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.Semantic proximity Read